Delayed
Japan Exchange
01:48:37 2024-06-17 am EDT
5-day change
1st Jan Change
5,870
JPY
-1.68%
-2.81%
-20.35%
Fukuda Denshi Co., Ltd.(TSE:6960) added to S&P Global BMI Index
September 19, 2022 at 12:00 am EDT
Fukuda Denshi Co., Ltd.(TSE:6960) added to S&P Global BMI Index
Fukuda Denshi Co., Ltd Announces Notice on Shareholder Proposal
May. 15
CI
Fukuda Denshi Co., Ltd. Revises Dividend Guidance for the Year Ending March 31, 2024
May. 12
CI
Fukuda Denshi Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024
May. 12
CI
Fukuda Denshi Co., Ltd. Announces Special Dividend for the Year Ended March 31, 2024
May. 12
CI
Fukuda Denshi Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024
Feb. 20
CI
Fukuda Denshi Co., Ltd. Provides Special Dividend Guidance for the Year Ending March 31, 2024
Feb. 20
CI
Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
Feb. 20
CI
Fukuda Denshi Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024
Feb. 20
CI
Senzime Licensee Fukuda Denshi Launches Integrated Tetragraph Module in Japanese Market
Feb. 07
CI
Tranche Update on Fukuda Denshi Co., Ltd.'s Equity Buyback Plan announced on January 31, 2024.
Jan. 31
CI
Fukuda Denshi Co., Ltd.'s Equity Buyback announced on January 31, 2024, has closed with 1,428,700 shares, representing 4.72% for ¥11,258.16 million.
Jan. 31
CI
Fukuda Denshi Co., Ltd. announces an Equity Buyback for 2,000,000 shares, representing 6.61% for ¥15,760 million.
Jan. 31
CI
Fukuda Denshi Co., Ltd. authorizes a Buyback Plan.
Jan. 30
CI
Fukuda Denshi’s Attributable Profit up 20.8% in Fiscal H1
Nov. 20
MT
Fukuda Denshi Co., Ltd. Provides Ordinary Dividend Guidance for the Ending March 31, 2024
Nov. 19
CI
Fukuda Denshi Co., Ltd. Announces Extra Dividend for the Second Quarter Ended September 30, 2023, Scheduled Date for Commencement of Dividend Payment of December 4, 2023 and Provides Dividend Guidance for the Ending March 31, 2024
Nov. 19
CI
Fukuda Denshi Co., Ltd. Announces Ordinary Dividend for the Second Quarter Ended September 30, 2023, Scheduled Date for Commencement of Dividend Payment of December 4, 2023
Nov. 19
CI
Fukuda Denshi Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
23-10-25
CI
Cross SYNC. Inc. announced that it has received ¥510 million in funding from a group of investors
23-08-29
CI
Fukuda Denshi Co., Ltd. Provides Extra Dividend Guidance for the Second Quarter-End and Year-End for the Year Ending March 31, 2024
23-07-30
CI
Fukuda Denshi Co., Ltd. Provides Ordinary Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024
23-07-30
CI
Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024
23-07-30
CI
Fukuda Denshi Announces Voting Results
23-07-03
CI
Fukuda Denshi Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024
23-05-22
CI
Fukuda Denshi Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
23-05-15
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.
More about the company
Last Close Price
5,970
JPY
Average target price
6,600
JPY
Spread / Average Target
+10.55%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1